Companies
BioInnovation Institute
founded in 2018 by the Novo Nordisk Foundation, BII's 12-month Venture Lab program gives each startup a €500,000 convertible loan plus lab space and mentorship; its March 2026 cohort backed 11 startups (seven human health, three planetary health, one quantum),…
- Country
- Denmark
venture-lab
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| finance-investment | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Independent commercial foundation supported by the Novo Nordisk Foundation | novonordiskfonden.dk |
| Research focus | Life sciences (therapeutics, health tech, bioindustrials), quantum, AI, and Power-to-X technologies | bii.dk · novonordiskfonden.dk |
| Facility | The BII Building located in Innovation District Copenhagen, including offices, shared laboratories, and a deep tech accelerator space | bii.dk · novonordiskfonden.dk |
| Grant | Awards include grants and convertible loans of up to €2.15M for Bio Studio and up to €1.8M-€2M for Venture Lab startups; €185M distributed 2018-2025 | bii.dk · novonordiskfonden.dk |
| Publications | CEO Jens Nielsen has published more than 850 scientific articles | people.equilar.com |
| Principal staff | Jens Nielsen (CEO), Pui Ling Lau (COO), Trine Bartholdy (CBO, Life Science), Markus J. Herrgård (CTO), Sofie Lorentzen (Chief People Officer) | bii.dk · people.equilar.com · theorg.com |
Independent sources: bii.dk · novonordiskfonden.dk · people.equilar.com · theorg.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Venture studios & biotech incubators | finance-investment | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.